Literature DB >> 7181488

Influence of subinhibitory concentrations of penicillin, cephalothin, and clindamycin on Staphylococcus aureus growth in human phagocytic cells.

G R Elliott, P K Peterson, H A Verbrugh, M R Freiberg, J R Hoidal, P G Quie.   

Abstract

After an initial 2-h incubation with phagocytic cells, the growth of surviving intracellular Staphylococcus aureus was examined in the presence of subinhibitory concentrations of penicillin, cephalothin, and clindamycin. One-tenth of the minimal inhibitory concentrations of these antibiotics markedly reduced bacterial growth in normal polymorphonuclear leukocytes. In contrast, when human alveolar macrophages were studied, no inhibition of growth was seen. Subinhibitory concentrations of these antibiotics and polymorphonuclear leukocytes acted synergistically to reduce intracellular survival of S. aureus. This synergy did not appear to be dependent upon the microbicidal potential of the leukocyte respiratory burst, since no differences were found when polymorphonuclear leukocytes obtained from patients with chronic granulomatous disease were compared with those from normal donors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7181488      PMCID: PMC185660          DOI: 10.1128/AAC.22.5.781

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Influence of cationic local anesthetics on the metabolism and ultrastructure of human alveolar macrophages.

Authors:  J R Hoidal; J G White; J E Repine
Journal:  J Lab Clin Med       Date:  1979-05

2.  Enhanced susceptibility of penicillin-resistant staphylococci to phagocytosis after in vitro incubation with low doses of nafcillin.

Authors:  H Friedman; G H Warren
Journal:  Proc Soc Exp Biol Med       Date:  1974-07

3.  Antibiotic uptake by alveolar macrophages.

Authors:  J D Johnson; W L Hand; J B Francis; N King-Thompson; R W Corwin
Journal:  J Lab Clin Med       Date:  1980-03

4.  Gentamicin antibacterial activity in the presence of human polymorphonuclear leukocytes.

Authors:  P Vaudaux; F A Waldvogel
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

5.  Enterotoxin-producing bacteria stools from Swedish United Nations soldiers in Cyprus.

Authors:  E Bäck; M Jonsson; T Wadström
Journal:  Infection       Date:  1978       Impact factor: 3.553

6.  Killing of oxacillin-exposed staphylococci in human polymorphonuclear leukocytes.

Authors:  V Lorian; B Atkinson
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

7.  Penetration of penicillin into human phagocytes containing gonococci.

Authors:  D R Veale; H Smith; K Witt
Journal:  Lancet       Date:  1975-02-08       Impact factor: 79.321

8.  Suppression of bacterial adherence by subminimal inhibitory concentrations of beta-lactam and aminoglycoside antibiotics.

Authors:  I Ofek; E H Beachey; B I Eisenstein; M L Alkan; N Sharon
Journal:  Rev Infect Dis       Date:  1979 Sep-Oct

9.  Enhancement of leukocyte activity against Escherichia coli after brief exposure to chloramphenicol.

Authors:  H Pruul; P J McDonald
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

10.  Luminol-amplified chemiluminescence: a sensitive method for detecting the carrier state in chronic granulomatous disease.

Authors:  E L Mills; K S Rholl; P G Quie
Journal:  J Clin Microbiol       Date:  1980-07       Impact factor: 5.948

View more
  24 in total

Review 1.  Activity of antibiotics against microorganisms ingested by mononuclear phagocytes.

Authors:  P J van den Broek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

2.  PEGylated liposome encapsulation increases the lung tissue concentration of vancomycin.

Authors:  Krishna Muppidi; Jeffrey Wang; Guru Betageri; Andrew S Pumerantz
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

3.  Effect of amoxycillin and clavulanic acid, alone and in combination, on human polymorphonuclear leukocyte function against Staphylococcus aureus.

Authors:  A Pascual; L Martínez Martínez; J Aragón; E J Perea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

Review 4.  The Role of Antibiotics in Modulating Virulence in Staphylococcus aureus.

Authors:  Elisabeth Hodille; Warren Rose; Binh An Diep; Sylvain Goutelle; Gerard Lina; Oana Dumitrescu
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

5.  Therapeutic relevance of penicillin-induced hypersensitivity of Staphylococcus aureus to killing by polymorphonuclear leukocytes.

Authors:  C Lam; A Georgopoulos; G Laber; E Schütze
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

6.  Interaction of beta-lactam antibiotics with the bactericidal activity of leukocytes against Escherichia coli.

Authors:  A Dalhoff
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

7.  Staphylococcal PknB as the first prokaryotic representative of the proline-directed kinases.

Authors:  Malgorzata Miller; Stefanie Donat; Sonja Rakette; Thilo Stehle; Thijs R H M Kouwen; Sander H Diks; Annette Dreisbach; Ewoud Reilman; Katrin Gronau; Dörte Becher; Maikel P Peppelenbosch; Jan Maarten van Dijl; Knut Ohlsen
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

8.  Efficacies of various antimicrobial agents in treatment of Staphylococcus aureus abscesses and correlation with in vitro tests of antimicrobial activity and neutrophil killing.

Authors:  D M Bamberger; M T Fields; B L Herndon
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

9.  Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.

Authors:  Anne Sandberg; Jonas H R Hessler; Robert L Skov; Jens Blom; Niels Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

10.  Effect of ciprofloxacin on phagocytosis.

Authors:  A Forsgren; P I Bergkvist
Journal:  Eur J Clin Microbiol       Date:  1985-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.